Replies to post #110969 on Biotech Values

[spongepaul]

Tinker, Am I mistaken? If a clinical trial was required for generic copaxone, wouldn't the FDA just be looking for safety profile. If so, wouldn't they be able to show safety with a smaller group in a year or so?
TIA -Paul